Abstract:Although the advance in radiotherapy (RT) enables the deposition of stronger doses at tumor tissue, inadequate dose in radio-resistant glioblastoma multiforme (GBM) cells has hindered the therapeutic benefits. Herein, we demonstrated targeted sensitization-enhanced radiotherapy (TSER), a strategy that could achieve precision cell-targeted RT using linear accelerators. TSER combines a novel radio-enhancer GoldenDisk (GD), 5-aminolevulinic acid (5-ALA), low-intensity ultrasound (US), and low-dose RT showed a synergized radio-enhancement and radio-sensitization effects. Both 5-ALA and GD with its hyaluronic-acid-immobilized, gold nano-particle core-silica shell structure selectively accumulated in GBM, which synergistic-ally sensitized GBM cells to radiation under US application. Moreover, long-lasting intracellular colloidal stability of GD allows the sustainable radio-enhancement effect throughout the course of treatment. Radio-enhancement/radio-sensitization effects were confirmed by monitoring viability of healthy astrocyte to GBM cell ratio, reactive oxygen species levels, DNA damage, intrinsic apoptosis, and cell cycle arrest. Encouragingly, TSER showed a superior therapeutic effect in an orthotropic GBM model with the use of only 20% of the radiation dose than did 10-Gy RT.

Low-Dose Precision Radiotherapy for Glioblastoma Multiforme Via Programmed Combination for Sensitized Radioenhancement